Intra-sphincteric botulinum toxin in the management of functional biliary pain
Endoscopy International Open, 2022 Background and study aims The management of functional biliary-type pain remains a clinical challenge. Intra sphincteric botulinum toxin putatively exerts an anti-spasmodic and anti-nociceptive effect.
Shyam Menon, Andrew Holt, Adam D. Farmer
doaj +1 more source
Can Botulinum toxin type A prevent kinetic horizontal forehead lines to become static ? A five year follow up study [PDF]
Ain-Shams Journal of Surgery, 2013 Background: Botulinum toxin type A injection has become a worldwide leading method for treating facial rhytides specially in women. Authors still debate whether or not regular administration of the toxin may delay or prevent kinetic horizontal ...
Asser EI-Hilaly +2 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2023 BackgroundThe COVID-19 pandemic has brought about significant changes in the medical field, yet the use of botulinum toxin type A has remained uninterrupted.
Xiangyu Liu +7 more
doaj +1 more source
The light chain but not the heavy chain of botulinum A toxin inhibits exocytosis from permeabilized adrenal chromaffin cells [PDF]
, 1989 The heavy and light chains of botulinum A toxin were separated by anion exchange chromatography. Their intracellular actions were studied using bovine adrenal chromaffin cells permeabilized with streptolysin O.
M. Gratzl +10 more
core +1 more source
Double Sandwich ELISA Modified Method for the Detection of Clostridium Botulinum Type E [PDF]
Journal of Fasa University of Medical Sciences, 2013 Background & Objective: A very small amount of botulinum toxin can cause death and on the other hand, there is no cure for its poison other than antitoxin.
Mohammad Ebrahim minaei, Mojtaba Saadati
doaj +1 more source
Idiopathic harlequin syndrome: successful therapy with botulium toxin [PDF]
Surgical & Cosmetic Dermatology, 2023 Harlequin syndrome is a rare autonomic disorder characterized by anhidrosis and lack of unilateral flushing of the face, which may affect the cervical and thoracic regions.
Thais Feres Moreira Lima +4 more
doaj +1 more source
IJU Case Reports, 2022 Introduction We report a case of deterioration of bladder compliance after botulinum toxin type A injection and discontinuation of medication for overactive bladder.
Naoki Wada +6 more
doaj +1 more source
Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity
Acta Médica Portuguesa, 2020 Botulinum toxin type A has been approved for spasticity management in poststroke patients. The adverse effects are generally of two types: those related to local injection; and those related to the systemic effects from spread of the toxin ...
Alexandre Camões- Barbosa +2 more
doaj +1 more source
Botulinum Toxin Type B vs Type A in Cervical Dystonia: A Meta - analysis of high quality trials
Acta Neurológica Colombiana, 2012 Introduction: cervical dystonia (CD) is a frequent disabling condition. Botulinum Toxin (BT) type A is effective for CD. BT type B is an alternative, but its use for patients who develop neutralizing antibodies against BT type A is debatable ...
Diana M. Prada G
doaj +2 more sources
The light chain of tetanus toxin inhibits calcium-dependent vasopressin release from permeabilized nerve endings [PDF]
, 1992 The effects of tetanus toxin and its light and heavy chain subunits on vasopressin release were investigated in digitonin-permeabilized neurosecretory nerve terminals isolated from the neural lobe of the rat pituitary gland.
Weller, U. +5 more
core +1 more source